1ST Source Bank Sells 129 Shares of HCA Healthcare, Inc. (NYSE:HCA)

1ST Source Bank lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,373 shares of the company’s stock after selling 129 shares during the quarter. 1ST Source Bank’s holdings in HCA Healthcare were worth $3,403,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the period. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth about $39,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare in the third quarter worth about $41,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 0.2 %

NYSE:HCA traded up $0.66 during mid-day trading on Friday, hitting $311.99. The company had a trading volume of 318,813 shares, compared to its average volume of 1,199,376. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1 year low of $263.22 and a 1 year high of $417.14. The business has a fifty day simple moving average of $356.94 and a 200-day simple moving average of $358.27. The firm has a market capitalization of $79.03 billion, a price-to-earnings ratio of 14.01, a PEG ratio of 1.21 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada lifted their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Finally, Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $387.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.